SYDNEY (Reuters) - Australian mental health researchers have developed a once-a-day pill they believe might stop or slow the onset of Alzheimer’s disease, with human trials expected within two months.
SYDNEY (Reuters) - Australian mental health researchers have developed a once-a-day pill they believe might stop or slow the onset of Alzheimer’s disease, with human trials expected within two months.